Skip to content
Homepage
MiracleCord
Claimed OIG Cleared

MiracleCord

875 N Michigan Ave, Chicago, IL 60611, United States
4.9

About this clinic

Quality, experience, and affordability:
It's why parents choose MiracleCord.

MiracleCord is a family cord blood and tissue stem cell bank, whose lab is AABB-accredited, FDA-approved, and CLIA-certified. This ensures they meet the highest standards in the industry for safety, quality, and reliability.

They preserve stem cells from your baby's cord blood and tissue, which is collected immediately after birth. They isolate the hematopoietic stem cells from cord blood and save all tissue cells, including mesenchymal stem cells. These stem cells are available immediately should your child or an immediate family member need stem-cell therapy.

Treatments offered

Contact information

875 N Michigan Ave, Chicago, IL 60611, United States

Office hours

Monday – Sunday
Open 24 hours

Patient reviews

4.9

Based on 238 Google reviews

5 ★
4 ★
3 ★
2 ★
1 ★

We decided to go with MiracleCord because the customer service was excellent from the beginning compared to others in the market. They were able to solve all of our questions very fast. The pickup at the hospital was fast and efficient and they confirmed onced the cord was received and properly stored. We are very happy with our decision. Thank you MiracleCord!

Maria L · August 28th, 2025

Really simple process with MiracleCord. I called them the day before my wife gave birth. A courier brought the packages to us within 2 hours. The doctors knew what to do with everything and once they're ready, you call the number and a courier is there within an hour. Recommended them to a few friends already who have used them. Very happy with their service and will continue to refer.

Christopher P · September 1st, 2025

MiracleCord gave me complete peace of mind as a new parent. The process was simple, the team was caring, and I feel confident knowing my baby’s future health is protected. Truly one of the best decisions I’ve ever made!

Diego Romero · August 31st, 2025